Fibrin degradation products, produced by glioma cell-associated fibrinolysis and the partial inhibition of cell growth and migration in tissue culture.
D000818:Animals; D001932:Brain Neoplasms / Q000097:blood* / Q000139:chemically induced; D002455:Cell Division / Q000187:drug effects; D002464:Cell Migration Inhibition; D046508:Culture Techniques; D005338:Fibrin Fibrinogen Degradation Products / Q000378:metabolism*; D005342:Fibrinolysis / Q000187:drug effects*; D005910:Glioma / Q000097:blood* / Q000139:chemically induced; D008770:Methylnitrosourea; D008854:Microscopy, Electron; D009374:Neoplasms, Experimental / Q000097:blood / Q000139:chemically induced; D010960:Plasminogen Activators / Q000032:analysis; D011817:Rabbits; D051381:Rats; D014148:Tranexamic Acid / Q000494:pharmacology
D005338:Fibrin Fibrinogen Degradation Products; D008770:Methylnitrosourea; D014148:Tranexamic Acid; D010960:Plasminogen Activators